• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

与囊性纤维化严重肝脏疾病风险增加相关的标志物。

A marker associated with increased risk for severe liver disease in cystic fibrosis.

机构信息

Center for Molecular Medicine and Therapeutics, Child and Family Research Institute, 950 West 28th Avenue, Vancouver, BC V5Z4H4, Canada.

出版信息

Clin Genet. 2010 May;77(5):434-5. doi: 10.1111/j.1399-0004.2009.01365_1.x.

DOI:10.1111/j.1399-0004.2009.01365_1.x
PMID:20447150
Abstract

Genetic modifiers of liver disease in cystic fibrosis Bartlett et al. (2009) The Journal of the American Medical Association 302: 1076-1083.

摘要

囊性纤维化肝病的遗传修饰物 Bartlett 等人（2009 年）《美国医学会杂志》302: 1076-1083.

相似文献

1
A marker associated with increased risk for severe liver disease in cystic fibrosis.与囊性纤维化严重肝脏疾病风险增加相关的标志物。
Clin Genet. 2010 May;77(5):434-5. doi: 10.1111/j.1399-0004.2009.01365_1.x.
2
Liver disease as risk factor for cystic fibrosis-related diabetes development.肝脏疾病作为囊性纤维化相关糖尿病发生的危险因素。
Acta Paediatr. 2007 May;96(5):736-9. doi: 10.1111/j.1651-2227.2007.00250.x. Epub 2007 Mar 23.
3
Genetic and biochemical markers of obstructive lung disease in the general population.普通人群中阻塞性肺疾病的遗传和生化标志物。
Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.
4
An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study.一种 MBL2 单倍型和 ABCB4 变体可调节囊性纤维化患者肝病的风险：一项多中心研究。
Dig Liver Dis. 2009 Nov;41(11):817-22. doi: 10.1016/j.dld.2009.03.012. Epub 2009 May 20.
5
Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.表面活性蛋白A1和A2（SFTPA1和SFTPA2）基因的常见单倍型与囊性纤维化肺部疾病严重程度的关联。
Pediatr Pulmonol. 2006 Mar;41(3):255-62. doi: 10.1002/ppul.20361.
6
Liver disease in cystic fibrosis.囊性纤维化中的肝脏疾病
Curr Opin Pulm Med. 2007 Nov;13(6):529-36. doi: 10.1097/MCP.0b013e3282f10a16.
7
Gene modifiers in pediatrics: application to cystic fibrosis.儿科中的基因修饰因子：在囊性纤维化中的应用
Adv Pediatr. 2004;51:5-36.
8
Hepatobiliary disease in patients with cystic fibrosis.囊性纤维化患者的肝胆疾病
Curr Opin Gastroenterol. 2009 May;25(3):272-8. doi: 10.1097/MOG.0b013e3283298865.
9
Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism.患有囊性纤维化的儿科患者的肝病与谷胱甘肽S-转移酶P1基因多态性相关。
Hepatology. 2002 Oct;36(4 Pt 1):913-7. doi: 10.1053/jhep.2002.35534.
10
Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening.自我报告的对囊性纤维化携带者筛查指南的熟悉程度的影响。
Obstet Gynecol. 2005 Jun;105(6):1355-61. doi: 10.1097/01.AOG.0000163251.54416.a6.

引用本文的文献

1
Assessment of Liver Fibrosis with the Use of Elastography in Paediatric Patients with Diagnosed Cystic Fibrosis.弹性成像技术在诊断为囊性纤维化的儿科患者中评估肝纤维化的应用。
Dis Markers. 2022 Mar 19;2022:4798136. doi: 10.1155/2022/4798136. eCollection 2022.
2
Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.评估诊断为囊性纤维化患者的肝纤维化和炎症的选定参数。
Mediators Inflamm. 2020 Mar 25;2020:5696185. doi: 10.1155/2020/5696185. eCollection 2020.
3
Aetiopathogenesis of liver changes in the course of cystic fibrosis, considering disturbances of the bile acid profile as well as genetic and immunological factors.
囊性纤维化病程中肝脏变化的病因学，考虑胆汁酸谱紊乱以及遗传和免疫因素。
Prz Gastroenterol. 2013;8(5):290-4. doi: 10.5114/pg.2013.38730. Epub 2013 Oct 28.